Editas Medicine, Inc.EDITNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-1.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-79.66%
202412.16%
20231.54%
202222.77%
2021-9.80%
202063.05%
20196.89%
20189.01%
201745.95%
2016202.34%